N-acetylcysteine + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Common Cold Associated With Cough
Conditions
Common Cold Associated With Cough
Trial Timeline
Jan 1, 2015 → Apr 1, 2015
NCT ID
NCT02379637About N-acetylcysteine + Placebo
N-acetylcysteine + Placebo is a phase 2 stage product being developed by Novartis for Common Cold Associated With Cough. The current trial status is completed. This product is registered under clinical trial identifier NCT02379637. Target conditions include Common Cold Associated With Cough.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02379637 | Phase 2 | Completed |
Competing Products
20 competing products in Common Cold Associated With Cough